Christopher & Banks Corporation
CBKCQ
$0.0001
$0.000.00%
| Weiss Ratings | CBKCQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | -- | |||
| Risk Index | -- | |||
| Risk Grade | -- | |||
| Reward Grade | -- | |||
| Rating Factors | CBKCQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | -- | |||
| Efficiency Index | -- | |||
| Solvency Index | -- | |||
| Total Return Index | -- | |||
| Volatility Index | -- | |||
| Beta / Standard Deviation | CBKCQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -91.53 | |||
| Price History | CBKCQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | -- | |||
| Year to Date Total Return | -- | |||
| 1-Year Total Return | 0.00% | |||
| 2-Year Total Return | 0.00% | |||
| 3-Year Total Return | 0.00% | |||
| 5-Year Total Return | -99.94% | |||
| 52-Week High % Change | 0.00% | |||
| 52-Week Low % Change | 9,900.00% | |||
| Price | CBKCQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.00 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Sep 18, 2024 | |||
| 52-Week High Price (Date) | Apr 08, 2024 | |||
| Valuation | CBKCQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 3.86K | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -1.29 | |||
| Earnings Per Share Growth | 308.87% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.00 | |||
| Price/Book (Q) | 0.00 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | CBKCQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 37.86M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | CBKCQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 763 551 5000 | |||
| Address | 2400 Xenium Lane North Plymouth, MN 55441 | |||
| Website | www.christopherandbanks.com | |||
| Country | United States | |||
| Year Founded | 1956 | |||
| Profitability | CBKCQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -18.11% | |||
| Profit Margin | -18.58% | |||
| Management Effectiveness | CBKCQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -15.74% | |||
| Return on Equity | -- | |||
| Income Statement | CBKCQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 259.53M | |||
| Total Revenue (TTM) | 259.53M | |||
| Revenue Per Share | $6.86 | |||
| Gross Profit (TTM) | 89.35M | |||
| EBITDA (TTM) | -39.27M | |||
| EBIT (TTM) | -47.03M | |||
| Net Income (TTM) | -48.23M | |||
| Net Income Avl. to Common (TTM) | -48.23M | |||
| Total Revenue Growth (Q YOY) | -22.61% | |||
| Earnings Growth (Q YOY) | -2,319.30% | |||
| EPS Diluted (TTM) | -1.29 | |||
| EPS Diluted Growth (Q YOY) | -3,000.00% | |||
| Balance Sheet | CBKCQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.20M | |||
| Cash Per Share (Q) | $0.03 | |||
| Total Current Assets (Q) | 56.16M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -33.58M | |||
| Current Ratio (Q) | 0.562 | |||
| Book Value Per Share (Q) | -$0.94 | |||
| Total Assets (Q) | 172.84M | |||
| Total Current Liabilities (Q) | 100.00M | |||
| Total Debt (Q) | 141.77M | |||
| Total Liabilities (Q) | 206.41M | |||
| Total Common Equity (Q) | -33.58M | |||
| Cash Flow | CBKCQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -1.31M | |||
| Cash from Financing (TTM) | 24.00M | |||
| Net Change in Cash (TTM) | -948.00K | |||
| Levered Free Cash Flow (TTM) | -9.40M | |||
| Cash from Operations (TTM) | -23.65M | |||
